T cell allorecognition via molecular mimicry.

T cells often alloreact with foreign human leukocyte antigens (HLA). Here we showed the LC13 T cell receptor (TCR), selected for recognition on self-HLA-B( *)0801 bound to a viral peptide, alloreacts with B44 allotypes (HLA-B( *)4402 and HLA-B( *)4405) bound to two different allopeptides. Despite extensive polymorphism between HLA-B( *)0801, HLA-B( *)4402, and HLA-B( *)4405 and the disparate sequences of the viral and allopeptides, the LC13 TCR engaged these peptide-HLA (pHLA) complexes identically, accommodating mimicry of the viral peptide by the allopeptide. The viral and allopeptides adopted similar conformations only after TCR ligation, revealing an induced-fit mechanism of molecular mimicry. The LC13 T cells did not alloreact against HLA-B( *)4403, and the single residue polymorphism between HLA-B( *)4402 and HLA-B( *)4403 affected the plasticity of the allopeptide, revealing that molecular mimicry was associated with TCR specificity. Accordingly, molecular mimicry that is HLA and peptide dependent is a mechanism for human T cell alloreactivity between disparate cognate and allogeneic pHLA complexes.

[1]  R. Lechler,et al.  The structural basis of alloreactivity , 1990, Immunologic research.

[2]  P. Marrack,et al.  Germline-encoded amino acids in the αβ T cell receptor control thymic selection , 2009, Nature.

[3]  Dominique Charron,et al.  HLA : genetic diversity of HLA functional and medical implication , 1997 .

[4]  J. McCluskey,et al.  How a Home-Grown T Cell Receptor Interacts with a Foreign Landscape , 2007, Cell.

[5]  J. Klein,et al.  HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation. , 1994, Bone marrow transplantation.

[6]  M. Gross,et al.  Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes , 2007, Nature Immunology.

[7]  L. K. Ely,et al.  T cell allorecognition and MHC restriction--A case of Jekyll and Hyde? , 2008, Molecular immunology.

[8]  K. Wucherpfennig,et al.  Structural features of autoreactive TCR that determine the degree of degeneracy in peptide recognition. , 1999, Journal of immunology.

[9]  V. Engelhard,et al.  Alloreactive cytotoxic T lymphocytes focus on specific major histocompatibility complex-bound peptides. , 1997, Transplantation.

[10]  J. McCluskey,et al.  The 1.5 A crystal structure of a highly selected antiviral T cell receptor provides evidence for a structural basis of immunodominance. , 2002, Structure.

[11]  James McCluskey,et al.  A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity. , 2003, Immunity.

[12]  M. Williams.  Rheumatic fever and the streptococcus: Another look at molecular mimicry , 1983 .

[13]  K. Garcia,et al.  Emerging principles for T cell receptor recognition of antigen in cellular immunity. , 1999, Reviews in immunogenetics.

[14]  M. Bevan,et al.  T cells respond preferentially to antigens that are similar to self H-2. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. McCluskey,et al.  Immunodominance Hierarchies and Gender Bias in Direct TCD8‐Cell Alloreactivity , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  D. Roelen,et al.  Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation , 2007, Bone Marrow Transplantation.

[17]  S. Sainsbury,et al.  T cell-mediated autoimmune disease due to low-affinity crossreactivity to common microbial peptides. , 2009, Immunity.

[18]  P. Travers,et al.  Similar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicry. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Burrows,et al.  An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease , 1994, The Journal of experimental medicine.

[20]  K. Garcia,et al.  How a Single T Cell Receptor Recognizes Both Self and Foreign MHC , 2007, Cell.

[21]  L R Pease,et al.  Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. , 1998, Science.

[22]  L. Sherman,et al.  The molecular basis of allorecognition. , 1993, Annual review of immunology.

[23]  L. K. Ely,et al.  Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition , 2009, The Journal of experimental medicine.

[24]  P. Fink,et al.  Positive selection of thymocytes. , 1995, Annual review of immunology.

[25]  J. McCluskey,et al.  The shaping of T cell receptor recognition by self-tolerance. , 2009, Immunity.

[26]  L. Sherman,et al.  Peptide-dependent recognition of H–2Kb by alloreactive cytotoxic T lymphocytes , 1989, Nature.

[27]  I. Doxiadis,et al.  Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept , 1996, The Lancet.

[28]  S. Yang,et al.  Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. , 1990, The New England journal of medicine.

[29]  D J Moss,et al.  Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus , 1994, The Journal of experimental medicine.

[30]  J. Whisstock,et al.  A Structural Basis for the Selection of Dominant αβ T Cell Receptors in Antiviral Immunity , 2003 .

[31]  M. Oldstone.  Molecular mimicry and autoimmune disease , 1987, Cell.

[32]  S. L. Silins,et al.  T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen , 1995, The Journal of experimental medicine.

[33]  D. Wilson,et al.  Histocompatibility antigen-activated cytotoxic T lymphocytes. I. Estimates of the absolute frequency of killer cells generated in vitro , 1977, The Journal of experimental medicine.

[34]  Natalie A. Borg,et al.  CD1d–lipid-antigen recognition by the semi-invariant NKT T-cell receptor , 2007, Nature.

[35]  L. Sherman,et al.  Alloreactive T cells discriminate among a diverse set of endogenous peptides. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[36]  L. K. Ely,et al.  The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition , 2005, Nature Immunology.

[37]  James McCluskey,et al.  Antigen ligation triggers a conformational change within the constant domain of the alphabeta T cell receptor. , 2009, Immunity.

[38]  M. Bevan,et al.  High determinant density may explain the phenomenon of alloreactivity. , 1984, Immunology today.

[39]  P. A. Peterson,et al.  Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes. , 1998, Immunity.

[40]  W. Dröge.  Hypothesis on the origin of the strong alloreactivity. , 1979, Immunobiology.

[41]  Philippa Marrack,et al.  Crossreactive T Cells spotlight the germline rules for alphabeta T cell-receptor interactions with MHC molecules. , 2008, Immunity.

[42]  Kimberly R. Jordan,et al.  Use of baculovirus MHC/peptide display libraries to characterize T‐cell receptor ligands , 2006, Immunological reviews.

[43]  Philippa Marrack,et al.  Many different Vβ CDR3s can reveal the inherent MHC reactivity of germline-encoded TCR V regions , 2009, Proceedings of the National Academy of Sciences.

[44]  R. Zinkernagel,et al.  Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic system , 1974, Nature.

[45]  Robyn L Stanfield,et al.  How TCRs bind MHCs, peptides, and coreceptors. , 2006, Annual review of immunology.

[46]  J. McCluskey,et al.  Alloreactivity between Disparate Cognate and Allogeneic pMHC-I Complexes Is the Result of Highly Focused, Peptide-dependent Structural Mimicry* , 2006, Journal of Biological Chemistry.

[47]  Bernard Malissen,et al.  Crystal structure of a T cell receptor bound to an allogeneic MHC molecule , 2000, Nature Immunology.

[48]  M. Jackson,et al.  Peptide-independent Recognition by Alloreactive Cytotoxic T Lymphocytes (CTL) , 1997, The Journal of experimental medicine.

[49]  D. Garboczi,et al.  Shapes of MHC restriction. , 1999, Immunity.

[50]  R. Lechler,et al.  Allorecognition and the alloresponse: clinical implications. , 2007, Tissue antigens.

[51]  R. Poljak,et al.  The basics of binding: mechanisms of antigen recognition and mimicry by antibodies. , 1993, Current opinion in immunology.

[52]  J. Strominger,et al.  Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein , 1995, Cell.

[53]  Z Reich,et al.  Ligand recognition by alpha beta T cell receptors. , 1998, Annual review of immunology.

[54]  J. McCluskey,et al.  The Structure of HLA-B8 Complexed to an Immunodominant Viral Determinant: Peptide-Induced Conformational Changes and a Mode of MHC Class I Dimerization1 , 2002, The Journal of Immunology.

[55]  V. Engelhard,et al.  Role of endogenous peptide in human alloreactive cytotoxic T cell responses. , 1992, International immunology.

[56]  Natalie A Borg,et al.  T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I–bound peptide , 2005, Nature Immunology.

[57]  T. Ohta,et al.  Population Biology of Antigen Presentation by MHC Class I Molecules , 1996, Science.

[58]  James McCluskey,et al.  Human leukocyte antigen phenotype imposes complex constraints on the antigen‐specific cytotoxic T lymphocyte repertoire , 1997, European journal of immunology.

[59]  M. Bevan,et al.  Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? , 1977, Cellular immunology.

[60]  C. Janeway,et al.  Ligand thresholds at different stages of T cell development. , 1990, International immunology.

[61]  L. K. Ely,et al.  Natural HLA Class I Polymorphism Controls the Pathway of Antigen Presentation and Susceptibility to Viral Evasion , 2004, The Journal of experimental medicine.

[62]  I. Mackay,et al.  Molecular mimicry: a critical look at exemplary instances in human diseases , 2000, Cellular and Molecular Life Sciences CMLS.

[63]  Shunichi Kato,et al.  High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. , 2007, Blood.

[64]  J. McCluskey,et al.  T-cell allorecognition: a case of mistaken identity or déjà vu? , 2008, Trends in immunology.

[65]  James McCluskey,et al.  A Naturally Selected Dimorphism within the HLA-B44 Supertype Alters Class I Structure, Peptide Repertoire, and T Cell Recognition , 2003, The Journal of experimental medicine.

[66]  P. Parham,et al.  The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. , 1992, Journal of immunology.

[67]  M. Bevan,et al.  Positive selection of CD8+ T cells induced by major histocompatibility complex binding peptides in fetal thymic organ culture , 1993, The Journal of experimental medicine.

[68]  J. A. Payne,et al.  Differential transport requirements of HLA and H-2 class I glycoproteins , 2004, Immunogenetics.